CGEM - Financial Reports List - Cullinan Oncology, Inc. - IntrinsicAlpha

Cullinan Oncology, Inc. CGEM

Healthcare - Biotechnology - NASDAQ - US

$ 8.1

2.66 %

$ 474 M

Market Cap

-2.91

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	0.00%	-100.17%	-21.02%
Quarterly Report	Q3	8-K	2024-09-30	0.00%	-3.51%	-7.98%
Quarterly Report	Q2	8-K	2024-06-30	0.00%	-30.47%	-33.03%
Quarterly Report	Q1	8-K	2024-03-31	0.00%	35.91%	31.50%
Quarterly Report	Q4	8-K	2023-12-31	0.00%	12.13%	-39.49%
Annual Report	FY	10-K	2023-12-31	0.00%	-137.72%	-132.11%
Quarterly Report	Q3	8-K	2023-09-30	0.00%	-57.42%	-52.00%
Quarterly Report	Q2	8-K	2023-06-30	0.00%	-18.42%	-15.69%
Quarterly Report	Q1	8-K	2023-03-31	0.00%	-349.60%	-92.17%
Quarterly Report	Q4	8-K	2022-12-31	100.00%	16.69%	5.06%

1